期刊文献+

细胞凋亡及凋亡相关蛋白bcl-2在Barrett食管及食管腺癌发病中的作用 被引量:3

The Role of Apoptosis and Apoptosis-related Proteins bcl-2 in the Development of Barrett's Esophagus and Esophageal Adenocarcinoma
原文传递
导出
摘要 目的探讨Barrett食管(BE)发生并进展到食管腺癌(EA)过程中细胞凋亡及凋亡相关蛋白bcl-2表达的变化规律及意义。方法采用细胞凋亡原位检测技术(TUNEL法)和免疫组化法检测正常食管黏膜、Barrett食管上皮和食管腺癌3组标本细胞凋亡及bcl-2的表达情况,并进行组间比较和相关分析。结果EA的凋亡指数(AI)低于BE和正常食管上皮(P<0.01);bcl-2蛋白在正常食管黏膜、BE及EA中的表达呈升高趋势(r=0.406,P<0.01);在BE与EA中,bcl-2蛋白表达与细胞凋亡呈负相关(r=-0.507,P<0.01)。结论BE发生并向EA发展过程中,凋亡抑制机制可能起重要作用,而bcl-2可能通过抑制细胞凋亡参与BE及EA的发生发展。 Objective To investigate the role of apoptosis and apoptosis - related protein bcl-2 in the development of Barrett's esophagus(BE) and esophageal adenocarcinoma(EA). Methods The apoptotic index (AI) and the expression of bel-2 were studied in normal esophageal squamous epithelium, BE and EA by TUNEL method and immunohistochemieal staining respectively. The differences among the three groups were compared and the correlations were analyzed. Results ( 1 ) Apoptotic index in EA was higher than that in normal esophageal squamous epithelium and BE ( P 〈 0.01 ). (2) An increasing tendency in bel-2 staining was observed from normal esophageal squamous epithelium to BE and EA ( r = 0. 406, P 〈 0.01 ). (3)In BE and EA, the expression of bcl-2 had the inverse correlation with AI( r = - 0. 507, P 〈 0.01 ). Conclusion Inhibition of apoptosis, which Bcl-2 participates in, may impact on the course of the occurrence of BE and its progress to esophageal adenoeareinoma.
作者 赖圳宾 王雯
出处 《临床消化病杂志》 2010年第2期88-90,101,共4页 Chinese Journal of Clinical Gastroenterology
关键词 BARRETT食管 食管腺癌 细胞凋亡 BCL-2 Barrett' s esophagus Esophageal adenocarcinoma Apoptosis bcl-2
  • 相关文献

参考文献9

  • 1房殿春,许国铭,赵晶京.Barrett食管诊治共识(2005重庆草案)[J].胃肠病学和肝病学杂志,2006,15(1):80-81. 被引量:52
  • 2RUDIGER SIEWERT J,FEITH M,WERNERM,et al.Adenocarcinoma of the esophagogastric juncti on:results of surgicaltherapy based on anat omical/t opographic classificati on in 1,002 consecutive patients[J].Ann Surg,2000,232(3):3532.
  • 3KAWASKI H,ALTIERI DC,LU CD,et al.Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer[J].Cancer Res,1998,58(22):5071.
  • 4SHINOHARA T,OHSHIMA K,MURAYAMA H,et al.Apoptesis and proliferation in gastric carcinoma:the association with histological type[J].Histopathology,1996,29:123.
  • 5SASANO H,LMATANIi A,SHIZAWA S,et al.Cell proliferation and apoptosis in normal and pathologic human adrenal[J].Mod Pathol,1995,8:11.
  • 6AIHARA M,SCABDINO PT,TRUONG LD,et al.The frequency of apoptesis correlates with the prognosis of gleason grade 3 adenocarcinoma of the prostate[J].Cancer,1995,75:522.
  • 7HALM U,TANNAPFEL A,BREITUNG B,et al.Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus[J].Hepatogastro-enterology,2000,47(34):962.
  • 8VAN DER WOUDE CJ,JANSEN PL,TIEBOSCH AT,et al.Expression of apoptosis-related proteins in Barrett metaplasia-dysplasiacarcinoma sequence:a switch to a more resistant phenotype[J].Hum Pathol,2002,33:686.
  • 9SHIMIZU D,VALLBOHMER D,KURAMOCHI H,et al.Increasing cyclooxygenase-2(cox-2)gene expression in the progression of Barrett esophagus to adenocarcinoma correlates with that of bcl-2[J].Int J Cancer,2006,119(4):765.

二级参考文献4

  • 1张肇炽.线性代数及其应用[M]西北工业大学出版社,1992.
  • 2[美]凯莱(J·L· Kelly ) 著,吴从忻,吴让泉.一般拓扑学[M]科学出版社,1982.
  • 3[美]鲍姆(John D· Baum) 著,蒲思立.点集拓扑学原理[M]人民教育出版社,1981.
  • 4张肇炽.一个常用矩阵命名与记法的商榷[J].高等数学研究,1999,2(4):19-20. 被引量:2

共引文献51

同被引文献21

  • 1Cameron M Smith,David I Watson,Michael Z Michael,Damian J Hussey.MicroRNAs, development of Barrett’s esophagus, and progression to esophageal adenocarcinoma[J].World Journal of Gastroenterology,2010,16(5):531-537. 被引量:23
  • 2王鲁平,虞积耀,丁华野.食管胃交界部位病变[J].临床与实验病理学杂志,2004,20(6):647-649. 被引量:6
  • 3房殿春,许同铭,赵晶京.Barrett食管诊治共识(草案,2005,重庆)[J].中华消化杂志,2006,26(2):138-139. 被引量:53
  • 4Lofdahl HE, Lane A, Lu Y, et al. Increased population prevalence of reflux and obesity in the United Kingdom compared with Swe- dena potential explanation for the difference in incidence of e- sophageal adenocarcinoma [J]. Eur J Gastroenterol Hepatol, 2011,23(2) :128-132.
  • 5Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer:o- rient to occident. Effects of chronology, geography and ethnicity[J]. J Gastroenterol Hepatol,2009,24(5):729 -735.
  • 6Neumann H, Monkemiiller K, Vieth M, et al. Chemoprevention of adenocarcinoma associated with Barrett' s esophagus., potential options[J]. Dig Dis,2009,27(1) :18-23.
  • 7Wilkinson NW, Black JD, Roukhadze E, et al. Epidermal growth factor receptor expression correlates with histologic grade in re- sected esophageal adenocarcinoma[J]. J Gastrointest Surg, 2004, 8(4) :448-453.
  • 8Pinto C, DiFabio,Barone C,et al. Phase H study of eetuximab in combi- nation with cisplatin and docetaxel in patients with untreated advanced gastric or gastrooesophageal junction adenocarcinoma(DOCETLlX stud- y)[J]. Br J Cancer,2009,101(8) :1261-1268.
  • 9Moinard C, Cynober L, de Bandt JP. Polyamine metabolism and implications in human diseases[J].Clinical Nutrition, 2005,24(2):184-197.
  • 10Pegg AE. Mammalian polyamine metabolism and function[J]. IUBMB Life,2009,61(9) :880-894.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部